Prediction of longer-term outcome of treatment-resistant depression in tertiary care
Authors:
- Abebaw FekaduAFAbebaw Fekadu
- Lena J. RaneLRLena J. Rane
- Sarah C. WoodersonSWSarah C. Wooderson
- Kalypso MarkopoulouKMKalypso Markopoulou
- Lucia PoonLPLucia Poon
- Anthony J. CleareACAnthony J. Cleare
- 1 November 2012
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 201 (5) , 369-375
Abstract
Background: Systematic studies on the outcome of treatment-resistant depression are scarce.Aims: To describe the longer-term outcome and predictors of outcome in treatment-resistant depression.Method: Out of 150 patients approached, 118 participants with confirmed treatment-resistant depression (unipolar, n= 7; bipolar, n=27; secondary, n=14) treated in a specialist in-patient centre were followed-up for between 8 and 84 months (mean=39, s.d.=22).Results: The majority of participants attained full remission (60.2%), most of whom (48.3% of total sample) showed sustained recovery (full remission for at least 6 months). A substantial minority had persistent subsyndromal depression (19.5%) or persistent depressive episode (20.3%). Diagnosis of bipolar treatment-resistant depression and poorer social support were associated with early relapse, whereas strong social support, higher educational status and milder level of treatment resistance measured with the Maudsley Staging Method were associated with achieving quicker remission. Exploratory analysis of treatment found positive associations between treatment with a monoamine oxidase inhibitor (MAOl) in unipolar treatment-resistant depression and attaining remission at discharge and at final follow-up, and duloxetine use predicted attainment of remission at final follow-up.Conclusions: Although many patients with treatment-resistant depression experience persistent symptomatology even after intensive, specialist treatment, most can achieve remission. The choice of treatment and presence of good social support may affect remission rates, whereas those with low social support and a bipolar diathesis should be considered at higher risk of early relapse. We suggest that future work to improve the long-term outcome in this disabling form of depression might focus on social interventions to improve support, and the role of neglected pharmacological interventions such as MAOIs.Keywords
This publication has 30 references indexed in Scilit:
- Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort studyThe British Journal of Psychiatry, 2012
- What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studiesJournal of Affective Disorders, 2009
- The Maudsley Staging Method for Treatment-Resistant DepressionThe Journal of Clinical Psychiatry, 2009
- The influence of adversity and perceived social support on the outcome of major depressive disorder in subjects with different levels of depressive symptomsPsychological Medicine, 2006
- Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder?The Journal of Clinical Psychiatry, 2005
- Recovery from major depression: the role of support from family, friends, and spiritual beliefsActa Psychiatrica Scandinavica, 2004
- Outcome in refractory depressionJournal of Affective Disorders, 1999
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depressionJournal of Affective Disorders, 1990
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960